• TransMedics granted inducement equity awards on May 19, 2026, issuing non-qualified stock options for 37,367 shares and 24,848 restricted stock units to 14 new employees.
• Senior Vice President, General Counsel & Corporate Secretary Matthew S. Forsyth received options covering 23,171 shares and 15,409 restricted stock units.
• The options carry an exercise price of USD 66.13 per share, matching the stock’s May 19 close, with 25% vesting on the first anniversary of the start date and the balance vesting monthly over the next three years; the term is 10 years.
• Restricted stock units vest 25% on each of the first four anniversaries of the start date.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transmedics Group Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202605211605PR_NEWS_USPR_____NE65782) on May 21, 2026, and is solely responsible for the information contained therein.